917471-30-8 (5-(1-丙炔-1-基)吡啶-3-基硼酸,[5-(prop-1-yn-1-yl)pyridin-3-yl]boronic acid)

CAS号:
917471-30-8
中文名称:
5-(1-丙炔-1-基)吡啶-3-基硼酸
英文名称:
[5-(prop-1-yn-1-yl)pyridin-3-yl]boronic acid
安全信息:
分子式:
C8H8BNO2
分子量:
160.965621948242

5-(1-丙炔-1-基)吡啶-3-基硼酸(917471-30-8)名称与标识符

名称

中文别名:
5-(1-丙炔基)吡啶-3-硼酸 (含有数量不等的酸酐);(5-(丙-1-炔-1-基)吡啶-3-基)硼酸;[5-(丙炔-1-基)吡啶-3-基]硼酸;5-(1-丙炔)吡啶-3-硼酸;5-(1-丙炔-1-基)吡啶-3-基硼酸;
英文别名:
(5-(Prop-1-yn-1-yl)pyridin-3-yl)boronic acid;5-(1-Propynyl)pyridine-3-boronic Acid (contains varying amounts of Anhydride);5-(prop-1-ynyl)pyridin-3-ylboronic acid;Boronic acid, B-[5-(1-propyn-1-yl)-3-pyridinyl]-;[5-(5-PROP-1-YNYL-3-PYRIDYL)-3-PYRIDYL]BORONIC ACID;[5-(Prop-1-ynyl)pyridin-3-yl]boronic acid;3-propnynyl pyridine-5-boronic acid;(5-Prop-1-ynylpyridin-3-yl)boronic acid;[5-(prop-1-yn-1-yl)pyridin-3-yl]boronic acid;QICKHKWSOJEAII-UHFFFAOYSA-N;STL556138;BBL102338;RW2911;FCH1179034;AK104185;5-(Prop-1-ynyl)pyridine-3-ylboronic acid;AX8235724;5-(Prop-1-ynyl)pyridin-3-yl boron;B-[5-(1-Propyn-1-yl)-3-pyridinyl]boronic acid (ACI);F13763;917471-30-8;AKOS016006158;5-(Prop-1-ynyl)pyridin-3-yl boronic acid;5-(PROP-1-YN-1-YL)PYRIDIN-3-YLBORONIC ACID;SY102950;MFCD18258851;5-(1-Propynyl)pyridine-3-boronic Acid;C8H8BNO2;J-516385;AMY17900;A854119;DS-4223;FT-0687846;SCHEMBL931865;P2403;(5-(Prop-1-yn-1-yl)pyridin-3-yl)boronicacid;CS-0060830;DB-368142;

标识符

MDL:
MFCD18258851
InChIKey:
QICKHKWSOJEAII-UHFFFAOYSA-N
Inchi:
1S/C8H8BNO2/c1-2-3-7-4-8(9(11)12)6-10-5-7/h4-6,11-12H,1H3
SMILES:
OB(C1C=NC=C(C#CC)C=1)O

5-(1-丙炔-1-基)吡啶-3-基硼酸(917471-30-8)物化性质

实验特性

  • LogP : -0.86720
  • PSA : 53.35000
  • 沸点 : 384.8±52.0°C at 760 mmHg
  • 密度 : 1.21

计算特性

  • 精确分子量 : 161.06500
  • 氢键供体数量 : 2
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 2
  • 同位素质量 : 161.0648087g/mol
  • 重原子数量 : 12
  • 复杂度 : 206
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 拓扑分子极性表面积 : 53.4

5-(1-丙炔-1-基)吡啶-3-基硼酸(917471-30-8)安全信息

5-(1-丙炔-1-基)吡啶-3-基硼酸(917471-30-8)合成路线

合成路线:1 步
反应条件:
参考文献:
Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor
Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; et al, Bioorganic & Medicinal Chemistry Letters, 2012, 22(7), 2444-2449
合成路线:1 步
反应条件:
参考文献:
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
Stamford, Andrew W.; Scott, Jack D.; Li, Sarah W.; Babu, Suresh; Tadesse, Dawit; et al, ACS Medicinal Chemistry Letters, 2012, 3(11), 897-902
合成路线:1 步
反应条件:
参考文献:
Process Development of a Suzuki Reaction Used in the Manufacture of Lanabecestat
Ashworth, Ian W. ; Campbell, Andrew D.; Cherryman, Janette H.; Clark, Jemma; Crampton, Alex; et al, Organic Process Research & Development, 2018, 22(12), 1801-1808

5-(1-丙炔-1-基)吡啶-3-基硼酸(917471-30-8)参考资料

Reaxys RN:
15423691
PubChem CID: